関節鏡デバイスの世界市場-2022-2029

市場の概要

関節鏡デバイスの市場規模は、予測期間（2022-2029年）にCAGR9%で成長すると予測されています。

関節鏡デバイスは、関節の問題を診断し治療するためのプロセスです。外科医は、ボタン穴程度の小さな切り口から、光ファイバー式ビデオカメラを取り付けた細いチューブを挿入する関節鏡デバイスを使用します。患者さんの関節内の様子は、HDビデオモニターに映し出されます。

市場力学

関節鏡デバイスの世界市場は、技術の進歩、手術における関節鏡デバイスの採用の増加、ヘルスケア支出の増加によって牽引されています。

世界の筋骨格系疾患の負担増が市場成長の原動力

筋骨格系疾患は、世界における身体障害の主な原因であり、腰痛は160カ国において身体障害の最も大きな原因となっています。世界保健機関（WHO）によると、2022年7月、世界で約17億1,000万人が筋骨格系疾患を患っています。人口の増加と高齢化により、運動器疾患とそれに伴う機能制限を抱える人々の数は急速に増加しています。

さらに、リハビリテーションは、筋骨格系障害のある人の痛みを軽減し、筋力を増強し、身体の可動性と機能的能力を高めるのに効果的です。さらに、リハビリテーションは、入院や医療費の削減にも中心的な役割を果たしています。WHOの報告書によると、リハビリテーションは全人類に提供される重要な健康資源であり、ユニバーサル・ヘルス・カバレッジの達成に不可欠な要素です。

筋骨格系障害の大きな負担とその健康上の転帰から、リハビリテーションサービスを適切に提供するためのさらなる取り組みが必要です。筋骨格系疾患の有病率は年齢とともに増加し、若い人々もまた、多くの場合、所得が最も高い年頃に影響を受ける。また、運動器疾患はヘルスケア従事者の職業上の健康問題であり、特に看護師でその割合が高いです。筋骨格系疾患の患者数が増加していることが、世界の関節鏡デバイス市場を牽引しています。

関節鏡デバイスの高価格が市場成長の妨げとなる

しかし、関節鏡手術の限界は、専用器具のコストと、手術の専門知識を得るための高額なトレーニングが必要なことです。関節鏡では、小指、肩、肘の関節が日常的に検査・処置されます。足根管、股関節、手根管はあまり行われない関節です。

COVID-19の影響分析

COVID-19の登場は、世界の関節鏡デバイス市場にマイナスの影響を与えました。2020年6月にJournal of Arthroscopy and joint Surgeryに掲載された論文によると、この間、整形外科の負傷者数は激減しているとのことです。また、ほとんどの手術施設はこの時期に閉鎖されました。多くの患者は、COVID-19の間、患者に継続的なケアを提供するために不可欠な媒体として、遠隔医療にシフトしました。また、靭帯損傷の患者さんの多くは保存的アプローチが好まれ、より少ない手術室で済む代替術式が検討されました。より多くの手術は、COVID-19ウイルスの集団感染が減少した安全な時期に延期されました。手術が再開されたとき、関節鏡手術はより重要または緊急なものから、より重要でないものへとトリアージされる必要があります。選択的外科手術は、できれば併存疾患がなく、周術期合併症のリスクが少ない患者から開始することが望ましいです。

2022年現在、状況はCOVID-19から回復し、すべてのヘルスケア施設がオープンし、患者は世界的に市場を牽引する適切な治療法に容易にアクセスできるようになります。

目次

第1章 市場調査手法とスコープ

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場影響要因
  • 促進要因
    • 筋骨格系疾患の有病率の増加
    • 技術的進歩
  • 抑制要因
    • 関節鏡のインプラントや器具のコスト高
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 規制分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的取り組み
• まとめ

第7章 製品タイプ別

• 関節鏡用インプラント
• 関節鏡
• 関節鏡用インスツルメントとアクセサリー
• 関節鏡用体液管理装置
• 関節鏡下高周波処置具
• 関節鏡用シェービング
• 関節鏡下可視化装置

第8章 アプリケーション別

• 膝関節鏡
• 肩関節鏡
• 股関節鏡
• 足・足首関節鏡
• その他

第9章 エンドユーザー別

• 病院
• 外来手術センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第11章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• タイプ別ベンチマーク

第12章 企業プロファイル

• Arthrex
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Stryker Corporation
• Conmed
• DePuy Synthes
• Smith & Nephew
• Karl Storz GmbH & Co.KG
• Olympus America Inc.
• Vimax Sp. Z.o.o.
• Wright Medical Group N.V.
• Richard Wolf GmbH

第13章 関節鏡デバイスの世界市場-DataM

Market Overview

Arthroscopy Devices Market size was valued at US$ XX million in 2021 and is expected to reach US$ XX million by 2029, growing at a CAGR of 9% during the forecast period (2022-2029).

Arthroscopy is a process for diagnosing and treating joint problems. Surgeon uses arthroscopy devices that insert a narrow tube attached to a fiber-optic video camera through a small incision about the size of a buttonhole. The view inside the patient's joint is transmitted to a HD video monitor.

Market Dynamics

The global arthroscopy devices market is driven by technological advancements, increased adoption of arthroscopy devices in surgeries, and rising healthcare expenditure.

The rising burden of musculoskeletal disease worldwide drives the market growth

Musculoskeletal conditions are the main reason for disability worldwide, with low back pain being the single foremost cause of disability in 160 countries. According to the World Health Organization (WHO), in July 2022, around 1.71 billion people had musculoskeletal conditions worldwide. Because of population growth and aging, the number of people living with musculoskeletal conditions and associated functional limitations is increasing rapidly.

In addition, rehabilitation is efficacious in decreasing pain, building muscle strength, and enhancing physical mobility and functional ability in individuals with musculoskeletal disorders. Furthermore, rehabilitation plays a central role in reducing hospitalization and healthcare costs. According to the report from the WHO, rehabilitation is a crucial health resource provided to the whole population, and it is an essential part of attaining universal health coverage.

The heavy burden of musculoskeletal disorders and their health outcomes necessitate additional efforts to provide rehabilitation services appropriately. The prevalence of musculoskeletal conditions grows with age, and younger people are also affected, often during their peak income-earning years. Also, musculoskeletal disorders are a major occupational health problem among healthcare workers, and the majority is particularly high among nurses. The rising number of patients with musculoskeletal conditions drives the arthroscopy device market worldwide.

The high cost of arthroscopy devices will hamper the growth of the market

However, limitations of arthroscopy are the costs of the specialized devices and the necessary expansive training to gain expertise in the procedure. The stifle, shoulder, and elbow joints are routinely inspected and treated by arthroscopy. Less frequently accessed joints are the tarsus, hip and carpus.

COVID-19 Impact Analysis

The appearance of COVID-19 negatively impacted the global arthroscopy devices market. As per the article published in the Journal of Arthroscopy and joint Surgery in June 2020, the number of orthopedic injuries has seen a sharp fall during this time. Most surgical facilities were also closed at this time. Many patients shifted towards telemedicine as an essential medium of providing continued care to patients during COVID-19. Also, conservative approaches were preferred for most patients with ligament injuries, and alternative procedures requiring less operating room were explored. More surgeries were postponed to a safer time frame when the population's transmission of the COVID-19 virus has declined. When surgeries are resumed, arthroscopy procedures need to be triaged from more important or urgent to less important ones. Elective surgical procedures should preferably be started with patients with no co-morbidities and a lesser risk of peri-operative complications.

As of 2022, the situation is recovering from COVID-19, all healthcare facilities are opening, and patients can easily access the suitable therapies that drive the market globally.

Segment Analysis

The arthroscopy instruments and accessories segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The arthroscopy instruments and accessories segment accounts for the largest market share. Arthroscopic surgical instruments are developed to facilitate cutting and trimming with ergonomic designs and balanced weight. They are used in hand, hip, knee, shoulder, and other small joint procedures.

The market players are offering arthroscopy instruments and accessories in the market. For instance, Smith & Nephew (Arthrocare) FIRST PASS 22-4035 is produced for consistent and secure suture passing. Pass and retrieve the suture simultaneously with FIRST PASS. This suture management instrument is designed for one-handed use and can be assembled/disassembled using minimal steps.

In addition, Arthrex has revolutionized arthroscopic procedures worldwide. In the product portfolio, arthroscopes, arthroscopic sheath systems, competitive bridges, cameras, and cannulas make arthroscopy easier, more effective, and more efficient. Part of the SynergyUHD4 imaging system, these state-of-the-art devices make Arthrex imaging products the clear choice in orthopedic surgery.

Geographical Analysis

North America region holds the largest market share of the global Arthroscopy Devices market

North America dominates the market for arthroscopy devices and is anticipated to show a similar trend in the coming years. The market is propelled by factors such as advanced healthcare infrastructure-the increasing number of arthroscopies, active regional key players, and easy availability of regional products.

As per the Burden of Musculoskeletal Diseases in the United States (BMUS), musculoskeletal diseases impact more than one out of every two persons in the United States aged 18 and over and nearly three out of four aged 65 and over. Trauma, back pain, and arthritis are the three most familiar musculoskeletal conditions notified, and for which healthcare visits to physicians' offices, emergency departments, and hospitals occur every year.

In addition, the key players are offering a broad range of product portfolios in the North American region. For instance, Stryker provides fluid management, and resection Stryker's Integrated Arthroscopy Solution utilizes ReconiSense technology designed to optimize suction rates, enhance resection abilities, and maintain consistent visualization throughout Arthroscopic cases.

The Conmed offers arthroscopy devices for the shoulder, knee, hip, hand and wrist arthroscopy. The company offers Glass 4K Integrated Visualization System, Crystal view Pro Fluid Management System, Stealth Diamond-like Carbon Coated Blades, and Edge Bipolar Arthroscopic RF System.

Competitive Landscape

The arthroscopy devices market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Arthrex, Stryker Corporation, Conmed, DePuy Synthes, Smith & Nephew, Karl Storz GmbH & Co.KG, Olympus America Inc., Vimax Sp. Z.o.o., Wright Medical Group N.V., and Richard Wolf GmbH, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the arthroscopy devices market globally.

For instance,

• In February 2022, Formus Labs, the world's first automated 3D planner for joint replacement surgeries, declared that it had raised US$ 5 million and the public launch of its orthopedic surgery planning solution, which provides surgeons with exceptional insight into the pre-operation planning process. In addition, Formus Labs partnered with Zimmer Biomet to expand its business globally.

Arthrex, Inc.

Overview:

Arthrex is a global medical device company founded in 1981 focusing on new product development and medical education in orthopedics. the company is helping surgeons treat their patients better. The company has pioneered the field of arthroscopy and produces more than 1,000 innovative products and procedures every year.

Product Portfolio:

Alternative Bridge Systems: The bridge system is a type of arthroscopy accessory used to help maintain portals with metal cannulas. A typical bridge user will have two cannulas placed in the joint, one viewing portal and one working portal. The cannulas feature a J-Lock-type connection to the bridge, which permits quick and easy portal changes. The Arthrex shaver blades screw into the cannulas to make a seal which helps maintain distention in the joint.

The global arthroscopy devices market report would provide access to approximately 55+ market data tables, 55+ figures, and in the range of 200+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increase in Prevalence of Musculoskeletal Disorders
    • 4.1.1.2. Technological Advancements
  • 4.1.2. Restraints:
    • 4.1.2.1. High Cost of Arthroscopy Implants and Instruments
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturer's Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Arthroscopic Implants*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Arthroscopes
• 7.4. Arthroscopy Instruments and Accessories
• 7.5. Arthroscopy Fluid Management Devices
• 7.6. Arthroscopy Radiofrequency Devices
• 7.7. Arthroscopy Shaves
• 7.8. Arthroscopy Visualization Devices

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Knee Arthroscopy*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Shoulder Arthroscopy
• 8.4. Hip Arthroscopy
• 8.5. Foot & Ankle Arthroscopy
• 8.6. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Ambulatory Surgical Centers
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Key Developments and Strategies
• 11.2. Company Share Analysis
• 11.3. Type Benchmarking

12. Company Profiles

• 12.1. Arthrex*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Stryker Corporation
• 12.3. Conmed
• 12.4. DePuy Synthes
• 12.5. Smith & Nephew
• 12.6. Karl Storz GmbH & Co.KG
• 12.7. Olympus America Inc.
• 12.8. Vimax Sp. Z.o.o.
• 12.9. Wright Medical Group N.V.
• 12.10. Richard Wolf GmbH

LIST NOT EXHAUSTIVE

13. Global Arthroscopy Devices Market - DataM

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us